TRCT
IHI icon

Tower Research Capital (TRC)’s iShares US Medical Devices ETF IHI Stock Holding History

Tower Research Capital (TRC)’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.41M Sell
26,370
-32,646
-55% -$1.92M 0.04% 441
2025
Q4 		$3.67M Buy
59,016
+26,555
+82% +$1.64M 0.09% 200
2025
Q3 		$1.95M Sell
32,461
-4,193
-11% -$256K 0.05% 299
2025
Q2 		$2.3M Sell
36,654
-19,571
-35% -$1.18M 0.06% 283
2025
Q1 		$3.63M Buy
56,225
+7,553
+16% +$469K 0.11% 155
2024
Q4 		$2.84M Buy
48,672
+11,723
+32% +$697K 0.06% 277
2024
Q3 		$2.19M Buy
36,949
+22,686
+159% +$1.3M 0.06% 256
2024
Q2 		$799K Sell
14,263
-24,149
-63% -$1.35M 0.01% 940
2024
Q1 		$2.25M Sell
38,412
-27,397
-42% -$1.55M 0.05% 254
2023
Q4 		$3.55M Buy
65,809
+53,242
+424% +$2.6M 0.04% 341
2023
Q3 		$610K Buy
12,567
+6,017
+92% +$320K 0.02% 764
2023
Q2 		$370K Sell
6,550
-74,171
-92% -$4.09M 0.01% 1166
2023
Q1 		$4.36M Buy
80,721
+12,324
+18% +$656K 0.14% 92
2022
Q4 		$3.6M Buy
68,397
+68,393
+1,709,825% +$3.47M 0.15% 87
2022
Q3 		$0 Sell
4
-41,142
-100% -$2.13M ﹤0.01% 6258
2022
Q2 		$2.08M Buy
41,146
+13,078
+47% +$713K 0.05% 362
2022
Q1 		$1.71M Buy
28,068
+28,060
+350,750% +$1.67M 0.02% 608
2021
Q4 		$1K Sell
8
-28,871
-100% -$1.85M ﹤0.01% 5834
2021
Q3 		$1.81M Sell
28,879
-17,003
-37% -$1.08M 0.05% 292
2021
Q2 		$2.76M Sell
45,882
-122,970
-73% -$7.11M 0.07% 212
2021
Q1 		$9.3M Buy
168,852
+132,768
+368% +$7.36M 0.16% 114
2020
Q4 		$1.97M Sell
36,084
-144,330
-80% -$7.54M 0.06% 234
2020
Q3 		$9.01M Buy
180,414
+64,596
+56% +$3.13M 0.1% 30
2020
Q2 		$5.11M Buy
115,818
+71,748
+163% +$3.07M 0.21% 67
2020
Q1 		$1.66M Buy
+44,070
New +$1.86M 0.1% 124
2019
Q4 		– Sell
-1,200
Closed -$49K – 3904
2019
Q3 		$49K Buy
1,200
+582
+94% +$23.8K ﹤0.01% 1817
2019
Q2 		$25K Sell
618
-88,404
-99% -$3.35M ﹤0.01% 2027
2019
Q1 		$3.44M Sell
89,022
-98,568
-53% -$3.58M 0.21% 65
2018
Q4 		$6.25M Buy
187,590
+87,462
+87% +$3.03M 0.45% 31
2018
Q3 		$3.8M Sell
100,128
-113,982
-53% -$4.05M 0.28% 55
2018
Q2 		$7.16M Buy
214,110
+28,560
+15% +$930K 0.4% 43
2018
Q1 		$5.72M Buy
185,550
+97,662
+111% +$3.01M 0.49% 27
2017
Q4 		$2.54M Sell
87,888
-89,262
-50% -$2.57M 0.33% 53
2017
Q3 		$4.93M Buy
177,150
+26,136
+17% +$723K 0.41% 35
2017
Q2 		$4.19M Sell
151,014
-510
-0.3% -$13.5K 0.48% 32
2017
Q1 		$3.82M Buy
+151,524
New +$3.67M 0.38% 29
2016
Q3 		– Sell
-175,488
Closed -$3.96M – 4006
2016
Q2 		$3.96M Sell
175,488
-135,900
-44% -$2.94M 0.38% 41
2016
Q1 		$6.36M Buy
+311,388
New +$6.05M 0.95% 16
2015
Q4 		– Sell
-18,684
Closed -$347K – 4732
2015
Q3 		$347K Sell
18,684
-12,426
-40% -$250K 0.03% 194
2015
Q2 		$621K Sell
31,110
-142,806
-82% -$2.86M 0.06% 124
2015
Q1 		$3.49M Buy
173,916
+11,880
+7% +$232K 0.43% 23
2014
Q4 		$3.06M Buy
+162,036
New +$2.92M 0.3% 53
2014
Q3 		– Sell
-70,110
Closed -$1.19M – 4625
2014
Q2 		$1.19M Buy
+70,110
New +$1.15M 0.15% 72
2014
Q1 		– Sell
-168,342
Closed -$2.6M – 4660
2013
Q4 		$2.6M Buy
+168,342
New +$2.51M 0.43% 38

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Tower Research Capital (TRC)'s IHI Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its iShares US Medical Devices ETF (IHI) stake by 55% in Q1 2026, selling an estimated $1.92M and leaving 26,370 shares worth $1.41M. The position accounts for 0.04% of the portfolio, ranked #441.

Tower Research Capital (TRC) first reported a position in IHI in Q4 2013 and has held it in 44 quarters since. The position peaked at $9.3M in Q1 2021. 504 funds tracked by Wall St. Rank hold IHI as of Q1 2026.

  • Tower Research Capital (TRC) held 26,370 shares of iShares US Medical Devices ETF worth $1.41M as of Q1 2026.
  • Tower Research Capital (TRC) sold 32,646 iShares US Medical Devices ETF shares in Q1 2026, an estimated $1.92M.
  • iShares US Medical Devices ETF made up 0.04% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #441 holding.
  • Tower Research Capital (TRC) first reported a position in iShares US Medical Devices ETF in Q4 2013 and has held it in 44 quarters since.
  • Tower Research Capital (TRC)'s iShares US Medical Devices ETF position peaked at $9.3M in Q1 2021.
  • 504 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.